Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Mercury Pharmaceuticals Limited, Capital House, 85 King William Street, London EC4N 7BL, UK
Fentanyl 50 micrograms/ml Solution for Injection/Infusion.
| Pharmaceutical Form |
|---|
|
Solution for injection. A clear, colourless, sterile solution. |
Contains Fentanyl citrate the equivalent of 50 micrograms of Fentanyl in 1ml.
Each 2ml ampoule contains 100 micrograms of Fentanyl as Fentanyl citrate.
Each 10ml ampoule contains 500 micrograms of Fentanyl as Fentanyl citrate.
For the full list of excipients, see section 6.1
| Active Ingredient | Description | |
|---|---|---|
| Fentanyl |
Fentanyl is a potent µ-opioid analgesic with rapid onset of analgesia and short duration of action. Its primary therapeutic actions are analgesia and sedation and is approximately 100-fold more potent than morphine as an analgesic. Secondary effects of fentanyl on central nervous system (CNS), respiratory and gastro-intestinal function are typical of opioid analgesics and are considered to be class effects. |
| List of Excipients |
|---|
|
Sodium chloride |
2ml/10ml clear One point cut (OPC) glass ampoules, glass type I Ph. Eur. borosilicate glass, packed in cardboard cartons to contain 10 × 2ml/10ml ampoules.
Not all pack sizes may be marketed.
Mercury Pharmaceuticals Limited, Capital House, 85 King William Street, London EC4N 7BL, UK
PL 12762/0575
18/10/1999
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
